# Controlled Human Malarial Infection by Intravenous Injection of Plasmodium Falciparum Sporozoites in Non-Immune Adults

> **NCT01624961** · PHASE1 · COMPLETED · sponsor: **Sanaria Inc.** · enrollment: 30 (actual)

## Conditions studied

- Malaria

## Interventions

- **BIOLOGICAL:** PfSPZ Challenge

## Key facts

- **NCT ID:** NCT01624961
- **Lead sponsor:** Sanaria Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-06
- **Primary completion:** 2012-10
- **Final completion:** 2013-02
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2016-04-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01624961

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01624961, "Controlled Human Malarial Infection by Intravenous Injection of Plasmodium Falciparum Sporozoites in Non-Immune Adults". Retrieved via AI Analytics 2026-08-19 from https://api.ai-analytics.org/clinical/NCT01624961. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*